SCHEMBL23826470

SCHEMBL23826470

C[C@H](Nc1cc(C(=O)O)ccc1Br)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 10/20 0.48
▸ KMT2A Q03164 1/20 0.47
▸ TOP2A P11388 1/20 0.45
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ PTPN2 P17706 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ PTPN6 P29350 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ RIN1 Q13671 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MMP13 P45452 1/20 0.43
▸ LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23826473 1.00 GPR119 (0.48) GPR119KMT2ATOP2ANPC1ALDH1A1
SCHEMBL23826402 0.87 TOP2A (0.45) GPR119KMT2ATOP2ANPC1ALDH1A1
SCHEMBL23826400 0.87 TOP2A (0.45) GPR119KMT2ATOP2ANPC1ALDH1A1
SCHEMBL23826504 0.82 KDM1A (0.41) KMT2ANPC1MAPTRAB9AL3MBTL1
SCHEMBL23827000 0.80 KDM4E (0.56) GPR119KMT2ATOP2AKDM4EPKM
SCHEMBL23826586 0.80 EED (0.44) GPR119KMT2ATOP2ANPC1ALDH1A1
SCHEMBL23826582 0.80 EED (0.44) GPR119KMT2ATOP2ANPC1ALDH1A1
SCHEMBL23826712 0.79 GPR119 (0.46) GPR119KMT2ANPC1ALDH1A1MAPT
SCHEMBL23826716 0.79 GPR119 (0.46) GPR119KMT2ANPC1ALDH1A1MAPT
SCHEMBL31336630 0.79 GPR119 (0.46) GPR119KMT2ANPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL NIPPON SHINYAKU CO., LTD. (JP) 2022-01-27 — — US disclosed
EP-3882239-A1 1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE Nippon Shinyaku Co., Ltd. (JP) 2021-09-22 — — EP disclosed
CN-113302184-A 1,3, 4-oxadiazolinone compounds and drugs 日本新药株式会社 2021-08-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024921-A1 1,3,4-OXADIAZOLONE COMPOUND AND PHARMACEUTICAL PIM1, PIM3, PIM2 GPR119 3488/4885KMT2A 3641/4885TOP2A 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback